EWING, NJ--(Marketwire - November 07, 2008) - Highlighted Links DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced today that it has been chosen to make a corporate presentation at the Biotech 2008 conference at 2:30 p.m. on Monday, November 10th, 2008 at the Loews Philadelphia Hotel.
